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           Intestinal epithelial cells (IECs) are a critical cell 
population that maintains intestinal immune ho-
meostasis through both barrier function and the 
ability to actively modulate intestinal immune 
responses ( 1  –  3  ). One IEC-derived cytokine with 
immunomodulatory properties is thymic stromal 
lymphopoietin (TSLP) (  4  ). TSLP is a four-helix 
bundle cytokine that is expressed both in hu-
mans and mice. Despite poor sequence homol-
ogy, human and mouse TSLP exhibit similar 
biological functions (  4  ). Expression of TSLP is 
regulated by NF-    B and can be induced by ex-
posure to viral, bacterial, and parasitic pathogens, 
infl  ammatory cytokines, and the Th2 cell  –  asso-
ciated cytokines IL-4 and IL-13 (  3, 5  –  8  ). TSLP 
binds to its high affi   nity receptor, a heterodimer 
composed of a unique TSLPR     chain and the 
IL-7R     chain, that is expressed on hematopoi-
etic cell lineages, including B cells, T cells, mast 
cells, and DCs (  4, 5, 9  –  12  ). 
  In vitro studies demonstrated that TSLP-
conditioned human DCs can promote Th2 cell 
responses (  11, 13  –  15  ). Mechanistically, TSLP 
treatment of DCs induces Th2 cell diff  erentia-
tion by inhibiting IL-12 production while simul-
taneously inducing OX40L expression (  14  –  16  ). 
The in vivo functions of TSLP have been most 
extensively studied in the skin and the lung (  11, 
13, 17, 18  ). Transgenic overexpression of TSLP 
in cutaneous or pulmonary epithelial cells results 
in the onset of Th2 cytokine  –  mediated infl  am-
mation resembling atopic dermatitis or asthma, 
respectively (  17, 18  ). Based on these studies, it 
has been proposed that TSLP is both necessary 
and suffi   cient for the initiation of Th2 cytokine  –
  driven infl  ammation (  4, 19, 20  ). We recently 
showed that TSLP responsiveness is an impor-
tant component of early immunity to the intesti-
nal nematode pathogen   Trichuris   (  2  ). However, 
the mechanisms and absolute requirements for 
TSLP  –  TSLPR interactions in the regulation of 
intestinal immunity and infl   ammation in vivo 
remain undefi  ned. 
  In this study, we identify constitutive TSLP 
expression in IECs throughout the lower gastro-
CORRESPONDENCE  
  David Artis:  
 dartis@vet.upenn.edu
  Abbreviations used: BMDC, 
bone marrow  –  derived DC; 
DSS, dextran sodium sulfate; 
ES, excretory  –  secretory; H  &  E, 
hematoxylin and eosin; IBD, 
infl  ammatory bowel disease; 
IEC, intestinal epithelial cell; 
IEC-Sup, supernatant(s) from 
the IEC line CMT-93; IF, 
immunofl  uorescent; GI, gastro-
intestinal; MLN, mesenteric 
LN; PAS, periodic acid-Schiff  ; 
TSLP, thymic stromal 
lymphopoietin.   
  TSLP regulates intestinal immunity 
and infl  ammation in mouse models 
of helminth infection and colitis 
    Betsy C.     Taylor  ,    1       Colby     Zaph  ,    1       Amy E.     Troy  ,    1      Yurong    Du  ,    1     
  Katherine J.     Guild  ,    1       Michael R.     Comeau  ,    2     and   David     Artis      1     
  1  Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104 
  2 Infl  ammation Research, Amgen Inc., Seattle, WA 98119     
  Intestinal epithelial cells (IECs) produce thymic stromal lymphopoietin (TSLP); however, the 
in vivo infl  uence of TSLP  –  TSLP receptor (TSLPR) interactions on immunity and infl  amma-
tion in the intestine remains unclear. We show that TSLP  –  TSLPR interactions are critical for 
immunity to the intestinal pathogen   Trichuris  . Monoclonal antibody  –  mediated neutraliza-
tion of TSLP or deletion of the TSLPR in normally resistant mice resulted in defective 
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sections of the cecum and large intestine. In the cecum, 
TSLP was found predominately in mature enterocytes lo-
cated at the crypt table, whereas in the proximal large intes-
tine TSLP was expressed throughout the length of the crypt 
(  Fig. 1 B  ). The variable expression of TSLP throughout the 
length of the GI tract suggests diff  erential regulation de-
pending on the microenvironment. As TSLP expression can 
be induced through exposure to TLR ligands (  3, 5, 6, 15  ) 
and commensal bacteria have been demonstrated to infl  u-
ence cytokine production in the intestine (  25, 26  ), it is pos-
sible that alterations in the abundance or composition of 
communal bacterial populations in the distinct regions in the 
GI tract may infl  uence TSLP mRNA expression. Not with-
standing this, the high levels of basal expression and the ex-
tensive distribution pattern of TSLP in the crypts of the 
proximal large intestine suggest a possible regulatory func-
tion for IEC-derived TSLP in immune homeostasis within 
the large intestine. 
  In vivo neutralization of TSLP in WT mice results 
in susceptibility to   Trichuris   
  Challenge of genetically resistant mice with the intestinal 
nematode pathogen   Trichuris   results in the dynamic up-regula-
tion of TSLP mRNA in the large intestine early during infec-
tion (  8  ). Further, we recently demonstrated that in the absence 
of the TSLP receptor, genetically resistant mice exhibit an 
early defect in the clearance of   Trichuris   (  2  ). However, TSLP 
has been shown to infl  uence lymphocyte development both 
in vivo and in vitro (  10, 27, 28  ), and previous work has estab-
lished that alterations in the circulating levels of TSLP can in-
fl  uence the frequency and composition of B cell populations 
in vivo (  9  ). To investigate whether the impaired early immu-
nity to infection in the TSLPR      /      mice was caused by altera-
tions in immune cell development or a defi  nitive requirement 
for TSLP in protective immunity, we neutralized endogenous 
TSLP in genetically resistant animals during   Trichuris   infection 
using a neutralizing anti-TSLP mAb. Although mesenteric 
LN (MLN) cells isolated from control-treated WT mice at 
day 21 after infection produced IL-4 and IL-13 after antigen-
specifi   c restimulation, MLN cells isolated from anti-TSLP 
mAb  –  treated mice exhibited signifi  cantly reduced expression 
of these cytokines (  Fig. 2 A  ).   Consistent with a defect in Th2 
cell diff  erentiation in vivo, the frequency of IL-13  +   CD4  +   T 
cells was lower in MLNs isolated from anti-TSLP mAb  –
  treated mice than in control-treated mice (  Fig. 2 B  ). Expres-
sion of Th2 cytokines in the intestine leads to physiological 
changes in the intestinal epithelium, including increased cell 
turnover, goblet cell hyperplasia, and the elevated expression 
of goblet cell  –  associated genes that are correlated with worm 
expulsion (  29  –  35  ). Histological examination of ceca isolated 
from infected WT animals revealed goblet cell hyperplasia and 
increased mucin staining, consistent with the presence of Th2 
cytokines (  Fig. 2 C  ). In contrast, mucin staining of cecal tissue 
sections from anti-TSLP mAb  –  treated mice failed to show de-
tectable goblet cell responses (  Fig. 2 C  ). Expression of the 
goblet cell  –  specifi  c proteins RELM     and GOB5 were also 
intestinal (GI) tract, with the highest level of expression in 
the proximal large intestine. When challenged with   Trichuris  , 
genetically resistant WT mice in which TSLP was neutral-
ized or TSLPR      /      mice failed to express protective Th2 
cell  –  associated cytokines and maintained persistent parasites 
beyond day 34 after infection. Disruption of the TSLP  –
  TSLPR pathway additionally resulted in increased expression 
of IL-12/23p40, IFN-    , and IL-17A, and the development 
of severe infection-induced infl  ammation.  Recombinant 
TSLP inhibited production of IL-12/23p40 in DCs in vitro, 
and DCs isolated from infected TSLPR      /      mice exhibited 
dysregulated production of IL-12/23p40 ex vivo. Signifi  -
cantly, blockade of IFN-     in   Trichuris  -infected TSLPR      /      
mice restored expression of Th2 cytokines and host protective 
immunity. Additionally, TSLPR      /      mice exhibited elevated 
expression of proinfl  ammatory cytokines and early onset of 
intestinal infl  ammation in a mouse model of infl  ammatory 
bowel disease (IBD). Collectively, these data suggest that 
within the intestinal microenvironment, one function of TSLP  –
  TSLPR interactions may be to limit proinfl  ammatory cyto-
kine production and infl  ammation. 
    RESULTS   
  Constitutive expression of TSLP in IECs 
  The GI tract is composed of region-specifi  c microenviron-
ments defi  ned by the presence of distinct accessory cell and 
lymphocyte populations, and varied populations of com-
mensal bacteria (  21  –  23  ). The large intestine diff  ers from the 
small intestine in immunoregulatory pressures, as it carries a 
higher level of commensal bacteria and is a common site for 
intestinal infl  ammatory diseases like ulcerative colitis (  24  ). We 
sought to examine whether basal expression of TSLP diff  ered 
in these distinct microenvironments. There was low expres-
sion of TSLP in the small intestine of naive mice (  Fig. 1 A  ).   
TSLP mRNA expression was also detected throughout the 
large intestine, with the highest expression levels in the 
proximal large intestine (  Fig. 1 A  ). TSLP protein expression 
was examined by immunofl  uorescent (IF) staining of cryo-
    Figure 1.         TSLP is basally expressed in the large intestine.   (A)  RNA 
was isolated from sections of the intestine and expression of TSLP was 
analyzed by RT-PCR. Values represent the percentage of actin expres-
sion in each sample. Results represent means   ±   SEM. Ce, cecum; dis, 
distal; DSI, distal small intestine; prox, proximal. (B) IF staining of TSLP 
(red) in intestinal cryosections, costained with DAPI (blue). Prox LI, prox-
imal large intestine. Data represent two individual experiments with two 
to three mice per group. Bars, 50   μ  m.     JEM VOL. 206, March 16, 2009 
ARTICLE
657
decreased in the anti-TSLP mAb  –  treated mice (  Fig. 2 D  ). Fur-
ther, RELM     secretion, as determined by protein analysis of 
fecal samples, was also defective in infected mice treated with 
anti-TSLP mAb (  Fig. 2 E  ). Consistent with these defective 
Th2 cytokine responses, anti-TSLP mAb  –  treated mice failed 
to exhibit worm expulsion at day 21 after infection (  Fig. 2 F  ). 
These results identify that optimal expression of TSLP is criti-
cal for the development of pathogen-specifi  c Th2 cytokine 
responses and early immunity to   Trichuris  . 
  TSLP  –  TSLPR interactions are critical for immunity 
to   Trichuris   
  Deletion of TSLPR in normally resistant mice resulted in in-
creased IFN-     production and elevated worm burdens at day 
21 after infection (  2  ). In genetically resistant strains of mice, 
CD4  +   Th2 cell  –  mediated expulsion of   Trichuris   occurs be-
tween days 18  –  21, whereas genetically susceptible mice de-
velop persistent infection and retain parasites for the lifetime 
of the host (  36  ). However, impaired early worm expulsion is 
not always indicative of a failed host protective response. For 
example,   Trichuris  -infected mice defi  cient in inducible T cell 
co-stimulator fail to expel worms at day 18 after infection but 
are able to successfully mount a protective Th2 cytokine  –
  mediated response and clear infection by day 34 after infec-
tion (  32  ). Thus TSLP  –  TSLPR interactions could be required 
for optimal early Th2 cytokine responses but not for subse-
quent Th2 cell  –  mediated clearance of infection. 
  To determine whether blockade of the TSLP  –  TSLPR 
pathway resulted in persistent chronic infection or simply re-
sulted in delayed worm expulsion, TSLPR  +/+   and TSLPR      /      
mice were infected with   Trichuris  , and the kinetics of worm 
expulsion were monitored over 34 d. MLN cells isolated from 
infected TSLPR      /      mice failed to produce detectable levels 
of Th2 cytokines (  Fig. 3 A  ).   Histological examination of cecal 
sections also revealed defective Th2 cytokine  –  dependent gob-
let cell hyperplasia in infected TSLPR      /      mice in comparison 
to infected TSLPR  +/+   mice (  Fig. 3 B  ). Further, production 
of goblet cell  –  derived RELM     and GOB5 was decreased in 
infected TSLPR      /      mice compared with infected TSLPR  +/+   
mice (  Fig. 3 C  ). Luminal secretion of RELM     was also de-
creased and unsustained in infected TSLPR      /      mice (  Fig. 3 D  ). 
The defective Th2 cytokine responses functionally altered the 
outcome of infection, as TSLPR      /      mice failed to mediate 
worm expulsion even at a late time point and remained heav-
ily infected beyond day 34 after infection (  Fig. 3 E  ). Consistent 
with this, chronic infection was also observed in WT mice 
treated with anti-TSLP mAb, as they exhibited high worm 
burdens at day 34 after infection (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20081499/DC1). Col-
lectively, neutralization of TSLP and deletion of the TSLPR 
identify a critical role for TSLP  –  TSLPR interactions in the 
    Figure 2.         In vivo neutralization of TSLP in WT mice results in sus-
ceptibility to   Trichuris  .   (A)  Antigen-specifi  c cytokine production from 
restimulated MLN cells was determined by ELISA. (B) Frequencies of CD4  +  
IL-13  +   T cells in the MLNs after 72 h of antigen restimulation (percent-
ages are shown). Plots are gated on CD4  +   T  cells.  (C – E)  Anti-TSLP – treated 
mice fail to induce goblet cell responses after infection. (C) Paraffi  n sec-
tions of cecal tissue were stained with PAS/Alcian blue for goblet cell 
visualization. (D) Paraffi  n sections of cecal tissue were IF stained for 
RELM     and GOB5 (green) and costained with DAPI (blue). (E) Protein 
isolated from fecal pellets on various days after infection was analyzed 
by SDS-PAGE and immunoblotted for RELM    . N, naive, uninfected con-
trol. (F) Worm burdens were assessed at day 21 after infection. Results 
represent means   ±   SEM. Data represent three individual experiments 
with three to six mice per group. *, P   ≤   0.05. Bars, 50   μ  m.     
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dysregulation of Th cell responses. Histological examination 
of cecal sections taken at day 34 after infection revealed 
immune-mediated alterations in both WT and TSLPR      /      
mice (  Fig. 4 A  ).   Cecal sections from WT mice exhibited 
mini  mal to mild submucosal edema, mixed infl  ammatory cell 
infi  ltrate, and mild crypt hyperplasia indicative of a recent 
infection. In contrast, TSLPR      /      mice exhibited severe 
infection-induced infl  ammation characterized by severe sub-
mucosal edema and transmural infl  ammation with lym  pho-
cytic infi  ltrate in the muscularis, and mixed lymphocytic and 
neutrophilic infi  ltrate in the submucosa and lamina propria 
(  Fig. 4 A  ). Additionally, IECs in the TSLPR      /      mice ap-
peared activated, and numerous mitotic fi  gures were ob-
served (  Fig. 4 B  ). TSLPR      /      mice also exhibited foci of 
infl  ammation with disruption of crypt architecture (  Fig. 4 C  ). 
The severe infection-induced infl  ammation exhibited in the 
TSLPR      /      mice contrasts with the mild to moderate infl  am-
mation seen in genetically susceptible AKR mice that also 
exhibit chronic infection (  37  –  39  ). Similar pathology to the 
infected TSLPR      /      mice was also observed in infected anti-
TSLP mAb  –  treated WT mice (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20081499/DC1). 
  The presence of severe intestinal infl   ammation in the 
TSLPR      /      mice suggested that susceptibility to   Trichuris   was 
not solely caused by a lack of Th2 responsiveness but involved 
a more general dysregulation of infection-induced innate and 
adaptive immune responses. Consistent with this hypothesis, 
there was a signifi  cant increase in the frequency of CD4  +   
IFN-      +   T cells isolated from the MLNs of TSLPR      /      mice 
at days 21 and 34 after infection compared with WT mice 
(  Fig. 4 D  ; and Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20081499/DC1). Restimulated MLN cells 
isolated from infected TSLPR      /      mice exhibited signifi  cantly 
elevated production of IFN-     and IL-17A in comparison to 
infected WT mice after either antigen-specifi  c or polyclonal 
stimulation (  Fig. 4, E and F  ). Elevated levels of IFN-     and 
IL-17A were also observed in the   Trichuris  -infected WT anti-
TSLP mAb  –  treated mice at the same time points (Fig. S4). 
The heightened expression of IFN-     and IL-17A and the se-
vere intestinal infl  ammation exhibited upon disruption of the 
TSLP  –  TSLPR pathway demonstrates that susceptibility to in-
fection was not solely caused by the impairment of Th2 cyto-
kine responses but also by the development of an unregulated 
proinfl  ammatory cytokine response. 
  TSLP regulates DC production of IL-12/23p40 in vivo 
and in vitro 
  The development of an inappropriate pathogen-specifi  c CD4  +   
Th1 cell response upon the disruption of TSLP  –  TSLPR in-
teractions suggests an alteration in signals that infl  uence Th 
cell diff  erentiation. Previous in vitro studies demonstrated that 
TSLP could inhibit IL-12 secretion from human DCs (  13  –  15  ). 
Given the critical importance of IL-12 in the promotion 
of Th1 cell diff  erentiation, we next examined whether there 
was a dysregulation of DC-derived IL-12/23p40 early in 
infection. Analysis of CD11c  +   CD11b  +   DCs isolated from 
development of a host protective Th2 cytokine  –  dependent 
immune response to   Trichuris  . 
  Proinfl  ammatory cytokine production in the gut-associated 
lymphoid tissues is increased in the absence of TSLP 
  The defective production of Th2 cytokines and susceptibility 
to   Trichuris   after the disruption of the TSLP  –  TSLPR pathway 
could be the result of impaired responsiveness to infection or 
    Figure 3.         TSLP responsiveness is required for immunity to   Trichuris  .  
(A) TSLPR     /     mice are unable to induce Th2 cytokine production. Antigen-
specifi  c cytokine production from restimulated MLN cells was determined 
by ELISA. (B  –  D) TSLPR     /     mice have decreased goblet cell responses. ND, 
not detected. (B) Cecal sections from TSLPR  +/+   or  TSLPR    /     mice  were 
taken at day 20 after infection and stained with PAS/Alcian blue. (C) Paraf-
fi  n sections of cecal tissue were IF stained for RELM     and GOB5 (green) 
and costained with DAPI (blue). (D) Protein isolated from fecal pellets on 
various days after infection was analyzed by SDS-PAGE and immunoblot-
ted for RELM    . N, naive, uninfected control. (E) Worm burdens in TSLPR  +/+  
and TSLPR     /     mice were assessed at days 20 and 34 after infection. Re-
sults represent means   ±   SEM. Data represent three individual experiments 
with three to four mice per group. *, P   ≤   0.05. Bars, 50   μ  m.     JEM VOL. 206, March 16, 2009 
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  To examine the ability of IEC-derived TSLP to modu-
late DC function, an in vitro conditioning system was used. 
Bone marrow  –  derived DCs (BMDCs) were cultured over-
night in the presence of supernatants from the IEC line 
CMT-93 (IEC-Sup), which is known to express TSLP (  2  ). 
Control and conditioned BMDCs were subsequently stim-
ulated with LPS for 8 h. Exposure to IEC-Sup did not im-
pair the ability of DCs to respond to LPS, as IEC-Sup  –
  conditioned BMDCs exhibited normal up-regulation of 
surface expression of MHC class II and the co-stimulatory 
MLNs of infected TSLPR      /      mice showed increased produc-
tion of the proinfl  ammatory cytokines TNF-    and IL-12/23p40 
at day 10 after infection (  Fig. 5, A and B  ).   Additionally, levels 
of IL-12/23p40 mRNA were increased in the large intes-
tine of TSLPR      /      mice at day 12 after infection (  Fig. 5 C  ). 
Although we have previously shown dysregulation of DC-
derived IL-12/23p40 under homeostatic conditions (  2  ), 
these data demonstrate an in vivo role for TSLP in the reg-
ulation of infection-induced IL-12/23p40 production from 
intestinal DCs. 
    Figure 4.         TSLP  –  TSLR interactions limit proinfl  ammatory cytokine production and infection-induced infl  ammation.   (A – C)  TSLPR    /     mice 
have increased infection-induced infl  ammation. (A) Paraffi  n-embedded cecal sections from day 34 after infection were stained with H  &  E. (B) Epithelial 
cells in TSLPR     /     mice exhibit numerous mitotic fi  gures (arrowheads). (C) TSLPR     /     mice exhibit foci of infl  ammation with loss of crypt architecture. 
(D – F)  TSLPR    /     mice have increased proinfl  ammatory cytokine production at day 20 after infection. (D) Frequencies of CD4  +   IFN-   +   T cells in the MLNs at 
day 20 after infection (percentages are shown). (E) Antigen-specifi  c IFN-     production from restimulated MLNs was determined by ELISA. (F) Polyclonal 
IL-17A production from restimulated MLNs was determined by ELISA. Results represent means   ±   SEM. Data represent two to three individual experiments 
with three to four mice per group. *, P   ≤   0.05. Bars, 50   μ  m.     660 TSLP REGULATES INTESTINAL IMMUNITY AND INFLAMMATION   | Taylor et al. 
12/23p40. Consistent with their inhibition of IL-12/23p40, 
both IEC-Sup  –   or rTSLP-conditioned BMDCs induced 
fewer CD4  +   T cells to produce IFN-     in antigen-specifi  c 
co-culture assays (  Fig. 5 L  ). These results indicate that TSLP 
is important in the regulation of DC-derived IL-12/23p40 
both in vitro and in vivo. 
  TSLP is not required to initiate Th2 cytokine responses 
in the intestine 
  Previous studies in both skin and lung models of Th2 cyto-
kine  –  mediated allergic infl  ammation implicated TSLP as both 
necessary and suffi   cient to drive the development of Th2 cy-
tokine  –  dependent infl  ammation, suggesting that TSLP may 
be a   “  master switch  ”   for the development of Th2 cytokine 
molecules CD80 and CD86 as compared with uncondi-
tioned BMDCs (  Fig. 5 D  ). Further, conditioning with IEC-
Sup did not alter or inhibit LPS-induced production of 
TNF-     (  Fig. 5, E and G  ). However, IEC-Sup  –  conditioned 
DCs exhibited reduced production of IL-12/23p40 (  Fig. 5, 
F and H  ). As IEC-Sup contains multiple IEC-derived fac-
tors, we sought to determine the contribution of TSLP in 
the regulation of DC responses using rTSLP. Similar to the 
results with IEC-Sup, exposure of BMDCs to rTSLP did 
not alter their surface marker expression or production of 
TNF-     after LPS stimulation but did result in decreased 
IL-12/23p40 production in comparison to control-treated 
BMDCs (  Fig. 5, I  –  K  ). These fi  ndings demonstrate the abil-
ity of TSLP to selectively regulate DC production of IL-
    Figure 5.         TSLP inhibits DC production of IL-12/23p40 in vivo and in vitro.   (A and B) TSLPR     /     mice have increased DC-derived proinfl  ammatory 
cytokine production at day 10 after infection. Cells were isolated from MLNs and restimulated directly ex vivo with   Trichuris   ES antigen. Cells are gated on 
CD11c  +   CD11b +   populations (A, TNF-    ; B, IL-12/23p40). (C) IL-12/23p40 mRNA expression in the colon at day 12 after infection. Results represent means   ±   
SEM. N, naive, uninfected control. Inf, infected day 12. (D  –  F) IEC-Sup specifi  cally inhibit LPS-induced IL-12/23p40 production. (D) LPS-induced up-regula-
tion of MHC class II, CD80, and CD86. (E and F) BMDC cytokine production was measured using intracellular cytokine staining (E, TNF-    ; F, IL-12/23p40). 
(G and H) Cytokine secretion was assayed by ELISA of the supernatants (G, TNF-    ; H, IL-12/23p40). Med, media + LPS; Sup, IEC-Sup + LPS. (I  –  K) rTSLP specifi  cally 
inhibits LPS-induced IL-12/23p40 production. (I) LPS-induced up-regulation of MHC class II, CD80, and CD86. (J and K) BMDC cytokine production as measured 
using intracellular cytokine staining (J, TNF-    ; K, IL-12/23p40). (L) IEC and rTSLP conditioning of BMDCs decreased CD4  +   T cell production of IFN-     upon  co-
culture. Percentages are shown in A, B, E, F, and J  –  L. Data in A  –  C represent two individual experiments with three mice per group. Data in D  –  K represent three 
to fi  ve individual experiments, and data in L represent two individual experiments. Shaded histograms in D and I indicate control, unstimulated BMDCs.      JEM VOL. 206, March 16, 2009 
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Oral administration of DSS is toxic to IECs and induces 
IEC damage, barrier leakage, and exposure of subepithelial im-
mune cells to commensal bacteria. Barrier breakdown results in 
immune cell recruitment, increased expression of proinfl  am-
matory cytokines, and the development of focal ulcerations in 
the large intestine (  40  ). 
  WT and TSLPR      /      mice were exposed to 5% DSS in 
their drinking water for 4 days, and disease was assessed daily. 
DSS-treated TSLPR      /      mice exhibited rapid weight loss in 
comparison to treated WT mice, displaying weight loss as early 
as day 1 after treatment (  Fig. 7 A  ).   Increased weight loss in the 
TSLPR      /      mice correlated with early disease onset and in-
creased disease severity as measured by fecal consistency, rectal 
bleeding, general appearance, and weight loss (  Fig. 7 B  ). At 
day 4 after DSS treatment, sections from the mid-colon of 
DSS-treated WT mice revealed mild thickening of the muscu-
laris and a minimal presence of infl  ammatory cells. In contrast, 
tissue sections from DSS-treated TSLPR      /      mice exhibited 
severe thickening of the muscularis, a marked mucosal infl  am-
matory cell infi  ltrate, and large numbers of focal lesions char-
acterized by epithelial cell sloughing, increased infl  ammatory 
cell infi  ltrate, and complete loss of crypt architecture (  Fig. 7 C  ). 
Consistent with the increased severity of disease score and in-
fl  ammation, direct ex vivo organ culture of colonic segments 
displayed increased production of IL-12/23p40 in the DSS-
treated TSLPR      /      mice (WT, 0.18   ±   0.05 ng/ml/mg of tis-
sue; TSLPR      /     , 0.33   ±   0.08 ng/ml/mg of tissue). Ex vivo 
analysis of MLN cells from day 4 after DSS treatment demon-
strated an increased number of IFN-      +   CD4  +   T cells in DSS-
treated TSLPR      /      mice compared with WT DSS-treated 
mice (  Fig. 7 D  ). In addition, polyclonal restimulations of MLN 
cells harvested at day 4 after DSS  –  treated TSLPR      /      mice re-
vealed increased levels of IFN-     in comparison to DSS-treated 
WT mice (  Fig. 7 E  ). DSS-treated TSLPR      /      mice also dis-
played exacerbated colonic shortening, thickening, and enteric 
bleeding at day 6 after treatment compared with DSS-treated 
WT mice (  Fig. 7, F and G  ). Collectively, these results demon-
strate a previously unrecognized role for TSLP  –  TSLPR inter-
actions in the regulation of intestinal infl  ammation in a mouse 
model of IBD. 
    DISCUSSION   
  This study demonstrates a key role for TSLP  –  TSLPR in-
teractions in regulating intestinal immunity and infl  amma-
tion. We show for the fi  rst time that TSLP is constitutively 
expressed throughout the length of the GI tract at both the 
mRNA and protein level under homeostatic conditions. The 
TSLP  –  TSLPR pathway within the intestine is critical for 
host protective immunity, as disruption of TSLP  –  TSLPR 
interactions in vivo led to susceptibility to   Trichuris   infec-
tion. After infection, anti-TSLP mAb  –  treated WT mice and 
TSLPR      /      mice remained chronically infected, had elevated 
expression of IFN-     and IL-17A, and exhibited severe infec-
tion-induced infl  ammation. Disruption of the TSLP –  TSLPR 
pathway also resulted in dysregulated DC production of 
infection-induced IL-12/23p40. However, unlike models of 
responses (  17  –  19  ). The impaired immunity to   Trichuris   exhib-
ited after disruption of the TSLP  –  TSLPR pathway supports 
this model. However, anti-TSLP mAb treatment or deletion 
of TSLPR resulted in the exaggerated expression of IL-
12/23p40 in ex vivo  –  isolated DCs and heightened CD4  +   T 
cell  –  derived IFN-     production. To test whether TSLP  –
  TSLPR interactions were absolutely required or dispensable 
for   Trichuris  -induced Th2 cytokine responses,   Trichuris  -in-
fected TSLPR      /      mice were treated with neutralizing mAbs 
against IFN-     throughout the course of infection. If TSLP  –
  TSLPR interactions were necessary for Th2 cytokine re-
sponses, anti  –  IFN-      –  treated TSLPR      /      mice would remain 
susceptible to   Trichuris  . 
  After neutralization of IFN-     in infected TSLPR      /      mice, 
there was a marked reduction in the frequency of IFN-      +   
CD4  +   T cells in the MLNs at day 21 after infection compared 
with control-treated TSLPR      /      mice, consistent with the role 
of IFN-     in promoting Th1 responses (  Fig. 6 A  ).   Coincident 
with decreased levels of IFN-    , there was an increase in levels 
of IL-4, IL-5, and IL-13 secreted from antigen-restimulated 
MLN cells from anti  –  IFN-      –  treated TSLPR      /      mice com-
pared with the control-treated TSLPR      /      mice (  Fig. 6 B  ). 
Critically, the levels of IL-4, IL-5, and IL-13 in the anti  –  IFN-
      –  treated TSLPR      /      mice were comparable to those seen in 
resistant TSLPR  +/+   mice (  Fig. 6 B  ). Blockade of IFN-     did 
not aff  ect   Trichuris  -specifi  c IgG1 serum antibody levels (not 
depicted) but did inhibit the development of a   Trichuris  -spe-
cifi  c IgG2a serum antibody response, as serum levels of IgG2a 
in anti  –  IFN-      –  treated TSLPR      /      mice were comparable to 
levels in TSLPR  +/+   mice (  Fig. 6 C  ). Anti  –  IFN-     treatment 
also augmented levels of total serum IgE (Fig. S5, available at 
http://www.jem.org/cgi/content/full/jem.20081499/DC1). 
Goblet cell responses were restored as the expression of both 
GOB5 and RELM     was increased in anti  –  IFN-      –  treated 
TSLPR      /      mice (  Fig. 6, D and E  ). Further, histological exami-
nation revealed that the severe crypt elongation, edema, and 
inflammatory infiltrate present in the   Trichuris  -infected 
TSLPR      /      mice were absent after anti  –  IFN-     treatment 
(  Fig. 6 F  ). Critically, anti  –  IFN-     treatment also recovered im-
munity in the TSLPR      /      mice. Although control-treated 
TSLPR      /      mice exhibited persistent infection, anti  –  IFN-      –
  treated mice expelled their worms by day 34 after infection 
(  Fig. 6 G  ). These results demonstrate that in the absence of 
IFN-     in an in vivo system, TSLP-independent mechanisms 
exist that allow for the generation of a protective Th2 cytokine 
response in the intestine. 
  TSLPR      /      mice exhibit exaggerated expression 
of proinfl  ammatory cytokines and severe intestinal 
infl  ammation in dextran sodium sulfate (DSS)  –  induced colitis 
  As TSLP was not strictly required to generate a protective 
Th2 cytokine response in the intestine, we hypothesized that 
TSLP may limit proinfl  ammatory cytokine production and 
infl  ammation. To assess whether the ability of TSLP to infl  u-
ence intestinal immune responses extended beyond helminth 
infection, we used the DSS model of chemical-induced colitis. 662 TSLP REGULATES INTESTINAL IMMUNITY AND INFLAMMATION   | Taylor et al. 
intestinal Th2 cytokine responses. Additionally, we demon-
strate that TSLP  –  TSLPR interactions limit IL-12/23p40 and 
IFN-     production in the DSS model of chemical-induced 
intestinal infl  ammation. Consistent with the elevated pro-
infl  ammatory cytokine production, DSS-treated TSLPR      /      
mice displayed increased intestinal infl  ammation compared 
infl  ammation in the skin or the lung, we found that TSLP 
was not required for pathogen-specifi  c Th2 cytokine re-
sponses in the intestine. Infected TSLPR      /      mice treated 
with neutralizing anti  –  IFN-     antibodies recovered patho-
gen-specifi  c Th2 cytokine production and immunity, thus 
identifying TSLP-independent pathways for the initiation of 
    Figure 6.         TSLP is not required for the initiation of an intestinal Th2 cytokine response to   Trichuris  .   (A) Frequencies of CD4  +   IFN-   +   T cells isolated 
from the MLNs and stimulated directly ex vivo (percentages are shown). (B) Antigen-specifi  c cytokine production from restimulated MLN cells was determined 
by ELISA. (C) Antigen-specifi  c serum IgG2a levels. (D and E) Anti  –  IFN-     treatment (Tx) restored goblet cell function in TSLPR     /     mice. (D) Protein isolated from 
fecal pellets on various days after infection was analyzed by SDS-PAGE and immunoblotted for RELM    . (E) Paraffi  n sections of cecal tissue were IF stained for 
RELM     and GOB5 (green) and costained with DAPI (blue). (F) Day 34 cecal sections were stained with H  &  E. (G) Worm burdens were assessed at days 21 and 34 
after infection. Results represent means   ±   SEM. Data are representative of two individual experiments with three to four mice per group. *, P   ≤   0.05. Bars, 50   μ  m.     JEM VOL. 206, March 16, 2009 
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ferentiation in vivo. Directly, TSLP has been shown to pro-
mote   Il-4   gene transcription in CD4  +   T cells (  42  ). Although 
the exact mechanisms remain unknown, it is possible that 
TSLP-induced STAT5 activation plays a role in promoting 
  Il-4   gene transcription independently of IL-4, STAT6, or 
GATA-3 (  43  –  45  ). Once initiated, IL-4 may act in an auto-
crine fashion on CD4  +   T cell to activate STAT6 and up-reg-
ulate GATA-3 expression, promoting and stabilizing Th2 
cell diff  erentiation (  46, 47  ). Indirectly, TSLP could promote 
Th2 cell diff  erentiation by inducing innate cell production of 
IL-13, which could signal through STAT6 to promote prox-
imal events (including GATA-3 up-regulation) in Th2 cell 
diff  erentiation (  46, 47  ). Neither of these possibilities is mutu-
ally exclusive, however, and it is likely that TSLP acts through 
multiple pathways to promote Th2 cell diff  erentiation and 
Th2 cytokine production. 
  Although these data strongly support a role for TSLP in 
directly infl  uencing and promoting Th2 cytokine responses, 
our fi  nding that TSLP was not required for the initiation of 
pathogen-specifi  c Th2 cytokine responses identifi  es TSLP-
independent pathways for the generation of intestinal Th2 
cytokine responses. In the absence of TSLP it is possible that 
a combination of other Th2-promoting factors present in 
the intestine are able to compensate and either act alone or 
with WT animals. Collectively these results indicate that in 
addition to promoting Th2 cytokine responses, a function of 
TSLP in the intestinal microenvironment may be to either 
directly or indirectly inhibit proinfl  ammatory cytokine pro-
duction and help prevent the development of severe intesti-
nal infl  ammation. 
  The putative link between TSLP and the promotion of 
Th2 cell development has been well developed in both in vi-
tro and in vivo studies (  4, 19, 20  ). Initial in vitro studies 
found that human monocyte-derived DCs treated with TSLP 
induced CD4  +   T cells to produce IL-4 upon co-culture (  11, 
13, 15  ), and that TSLP-induced up-regulation of OX40L on 
DCs promoted CD4  +   Th2 cell diff  erentiation (  14  ). Recent 
work also demonstrated the ability of TSLP to directly infl  u-
ence CD4  +   T cells: in vitro treatment of purifi  ed CD4  +   T 
cells with TSLP induced T cell IL-4 production and Th2 cell 
diff  erentiation (  41, 42  ). Further, in the presence of TNF-     
or IL-1, TSLP has been shown to induce IL-5 and IL-13 
from mast cells (  5  ). Supporting these in vitro studies, the 
transgenic overexpression of TSLP by epithelial cells in the 
skin or the lung induces Th2 cytokine  –  mediated infl  amma-
tion in vivo (  17, 18  ). Thus, through its ability to infl  uence 
both innate cell populations as well as CD4  +   T cells, TSLP 
could contribute both directly and indirectly to Th2 cell dif-
    Figure 7.         TSLP  –  TSLPR interactions limit proinfl  ammatory cytokine production and infl  ammation in DSS colitis.   (A) Weight loss. (B) Total pathology 
score for WT and TSLPR     /     mice on 5% DSS. (C) Paraffi  n-embedded cecal sections from day 4 after DSS administration were stained with H  &  E. Bars, 50   μ  m. 
(D) Total number of CD4  +   IFN-   +   T cells isolated from the MLNs at day 4 after DSS. (E) Cytokine production from anti-CD3/anti-CD28  –  restimulated MLN cells 
was determined by ELISA. (F) Colon of day 6 DSS-treated WT and TSLPR     /     mice, Bars, 1 cm. (G) Colonic shortening. Data are presented as the percent length 
of naive. Results represent means   ±   SEM. Data are representative of three individual experiments with four to fi  ve mice per group. *, P   ≤   0.05; **, P   ≤   0.08.    664 TSLP REGULATES INTESTINAL IMMUNITY AND INFLAMMATION   | Taylor et al. 
shown to inhibit IL-12  –  induced STAT4 activation through 
the induction of suppressor of cytokine signaling 3 (  60  ). Fur-
ther studies are required delineate the molecular mechanisms 
through which TSLP creates a Th2-permissive microenviron-
ment in both the intestine and in other peripheral tissues. 
  Beyond a direct infl  uence on balancing production of 
pro- and antiinfl  ammatory cytokine production, TSLP may also 
regulate recruitment and/or retention of immune cells at the 
site of infection or infl  ammation. For example, TSLP treat-
ment of human mDCs induces expression of the chemokines 
CCL17 and CCL22, known ligands for CCR4, a chemokine 
receptor found on eff  ector Th2 cells (  11, 19  ). Thus, after ex-
posure to   Trichuris  , IEC-derived TSLP could be acting on in-
testinal DCs to simultaneously create conditions permissive to 
Th2 cell diff  erentiation and to promote Th2 eff  ector cell re-
cruitment or retention in the intestine. 
  As there is a strong correlation of increased TSLP expression 
and disease in human patients with Th2 cytokine  –  mediated dis-
eases such as atopic dermatitis and asthma, the TSLP  –  TSLPR 
pathway has emerged as a novel therapeutic target for allergic 
infl  ammatory disorders ( 11, 61 ). Supporting this, targeted block-
ade of the downstream OX40-OX40L pathway has been shown 
to successfully inhibit TSLP-induced and antigen-induced in-
fl  ammation in mouse and nonhuman primate models of asthma 
and atopic dermatitis (  62  ). However, the results of the present 
studies demonstrate that disruption of the TSLP  –  TSLPR path-
way may lead to elevated production of proinfl  ammatory cyto-
kines and a predisposition to intestinal infl  ammation. As such, 
these fi  ndings suggest that manipulation of the TSLP  –  TSLPR 
pathway in the treatment of allergic diseases will require careful 
management. Notwithstanding this, the ability of TSLP to in-
hibit IL-12/23p40 and IFN-     production suggests that TSLP-
based biologics may off  er a novel therapeutic modality in the 
treatment of IBD and other chronic infl  ammatory disorders. 
Consistent with this, TSLP exp  ression was decreased in intesti-
nal biopsies from patients with Crohn  ’  s disease, suggesting that 
increased TSLP expression may provide therapeutic benefi  ts 
(  15  ). Thus, the TSLP  –  TSLPR pathway may be a novel thera-
peutic target for a variety of infl  ammatory conditions associated 
with the overproduction of proinfl  ammatory cytokines. 
  MATERIALS AND METHODS 
  Animals, parasites, antigens, and infections.     WT C57BL/6J and OT-II 
transgenic mice were obtained from the Jackson Laboratory. TSLPR  +/+   and 
TSLPR      /      mice were obtained from J. Ihle (St. Jude  ’  s Children  ’  s Hospital, 
Nashville TN). Mice were bred and maintained in a specifi  c-pathogen free 
environment at the University of Pennsylvania. Animal protocols were ap-
proved by the University of Pennsylvania Institutional Animal Care and Use 
Committee (IACUC), and all experiments were performed according to the 
guidelines of the University of Pennsylvania IACUC.   Trichuris muris   was 
maintained in genetically susceptible animals (  63, 64  ); isolation of   Trichuris   ex-
cretory  –  secretory (ES) antigen and eggs was performed as previously described 
(  65  ). Mice were infected on day 0 with 150  –  200 embryonated eggs, and para-
site burdens were assessed at various time points after infection. Serum was 
analyzed by ELISA for   Trichuris  -specifi  c IgG2a, as previously described (  66  ). 
  Cytokines and mAbs.     Neutralizing mAb against IFN-     (XMG-6) was 
purifi   ed from ascites by ammonium sulfate precipitation and dialyzed 
against PBS. Mice were injected i.p. with 1 mg of antibody at the time of 
in concert to create a microenvironment permissive for Th2 
cell diff  erentiation. Candidates include cytokines such as IL-
25 and IL-33, as they have each been demonstrated to pro-
mote Th2 cytokine responses (  48, 49  ). Further, both IL-25 
and IL-33 have been shown to play important roles in im-
munity to   Trichuris   infection (  8, 39, 50  ). The Notch  –  Notch 
ligand pathway may also play a role in the generation of 
TSLP-independent Th2 cytokine responses in the intestine. 
Previous work has demonstrated that the Notch  –  Notch li-
gand interactions are important in mediating immunity to 
  Trichuris   (  51  ), and Notch may act either directly in the pro-
motion of Th2 cell diff  erentiation (  52  –  56  ) or through its in-
fl  uence on epithelial cell function (  57  ). Thus, TSLP may be 
another factor that, although not itself essential for the de-
velopment of Th2 cytokine responses in the intestine, is 
critical in combination with several other factors to create a 
Th2-permissive microenvironment. 
  The elevated levels of proinfl  ammatory cytokines and 
severe infection-induced infl  ammation displayed in both 
infected TSLPR      /      mice and anti-TSLP mAb  –  treated WT 
mice suggests that TSLP may be playing a role in limiting 
proinfl   ammatory cytokine production. This is further sup-
ported by the elevated expression of IL-12/23p40 and IFN-    , 
and the severe infl   ammation exhibited in the DSS-treated 
TSLPR      /      mice. Although these data appear contradictory to 
the established function of TSLP in directly promoting Th2 
cytokine responses, the ability of TSLP to modulate proin-
fl   ammatory cytokine production has been previously indi-
cated. In vitro studies showed that TSLP-treated DCs exhibit 
reduced production of IL-12/23p40 upon TLR ligation, and 
the ability of DC-derived OX40L to drive Th2 cell diff  eren-
tiation is critically dependent on the absence of IL-12 (  2, 11, 
14, 15  ). In addition, transgenic overexpression of TSLP in 
the skin decreased the frequency of CD4  +   IFN-      +   T cells in 
transgenic mice in comparison to normal littermate controls, 
and TSLPR      /      mice exhibited signifi  cantly increased IL-12 
mRNA levels in the lungs compared with WT animals after 
OVA-induced allergic infl  ammation (  13, 17  ). These fi  ndings 
are consistent with a role for TSLP in negatively regulating 
proinfl  ammatory cytokine production in DC populations in 
peripheral sites. Thus, the exaggerated Th2 cytokine  –  medi-
ated diseases in mice with transgenic overexpression of TSLP 
may be a result of simultaneous increases in Th2 cytokine re-
sponses and decreased expression of proinfl  ammatory cyto-
kines, including IL-12 and IFN-    , that would counterregulate 
developing Th2 cytokine responses. TSLP is known to pro-
mote expression of GATA-3 and IL-4, pathways that would 
inhibit expression of IFN-     (  46, 58  ), but molecular mecha-
nisms underlying its direct antiinfl  ammatory functions remain 
to be defi  ned. For instance, although TSLP has been demon-
strated to inhibit DC production of IL-12/23p40 (  2, 11, 14, 15  ), 
the signaling pathways induced by TSLP in DCs that reg-
ulate gene expression are unknown at present. TSLP may also 
act directly on CD4  +   T cells to limit Th1 and Th17 cell dif-
ferentiation. For example, TSLP is known to activate STAT5 
(  27, 59  ), and STAT5a activation in CD4  +   T cells has been JEM VOL. 206, March 16, 2009 
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tored for weight loss, rectal bleeding, and general appearance (piloerection and 
lethargy). Pathology was scored as follows: (a) weight loss (no change = 0;   <  5% = 
1; 6  –  10% = 2; 11  –  20% = 3;   >  20% = 4), (b) feces (normal = 0; pasty, semi-
formed = 2; liquid, sticky, or unable to defecate after 5 min = 4), (c) blood (no 
blood = 0; visible blood in rectum = 1; visible blood on fur = 2), and (d) general 
appearance (normal = 0; piloerection = 1; lethargy and piloerection = 2; mo-
tionless, sickly = 4). 
  Statistics.     Results represent means   ±   SEM unless otherwise stated. Statisti-
cal signifi  cance was determined by the Student  ’  s   t   test or the Wilcoxon 
Mann-Whitney test for nonparametric samples (*, P   ≤   0.05; **, P   ≤   0.08). 
  Online supplemental material.     Fig. S1 shows chronic   Trichuris   infection in 
WT mice treated with anti-TSLP mAb at day 34 after infection. Severe infection-
induced infl  ammation in anti-TSLP mAb  –  treated mice is displayed in Fig. S2. 
Increased frequencies of CD4  +   IFN-     +   cells in the MLNs at day 34 after infection 
in TSLPR      /      mice are displayed in Fig. S3. Fig. S4 shows the elevated levels of 
IFN-     and IL-17A in   Trichuris  -infected WT mice treated with anti-TSLP mAb. 
Fig. S5 depicts the increased levels of total serum IgE seen in   Trichuris  -infected 
TSLPR      /      mice treated with anti  –  IFN-     mAb. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20081499/DC1. 
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infection and every 5 days after infection. Neutralizing mAb against mouse 
TSLP (M702) was obtained from Amgen. Mice were injected i.p. with 1 mg 
of antibody at the time of infection and every 5 days after infection. rTSLP 
(fi  nal concentration of 10 or 100 ng/ml in in vitro cultures) was obtained 
from R  &  D Systems. 
  Isolation of cells.     At necropsy, MLNs were harvested and single-cell suspen-
sions were prepared in DMEM supplemented with 10% heat-inactivated FBS, 
2 mM glutamine, 100 U/ml penicillin, 100   μ  g/ml streptomycin, 25 mM 
Hepes, and 5   ×   10      5   M 2-ME. A portion of cells was analyzed ex vivo for cy-
tokine production by stimulating with 10   μ  g/ml brefeldin A, 50 ng/ml PMA, 
and 750 ng/ml ionomycin for 4  –  5 h. For DC experiments, MLN cells were 
restimulated in the presence of 50   μ  g/ml of   T. muris   ES antigen and 10   μ  g/ml 
brefeldin A. Cells were harvested and stained with fl  uorochrome-conjugated 
antibodies against CD4, IFN-    , IL-13, CD11c, CD8    , CD11b, TNF-    , and 
IL-12/23p40. Cells were analyzed by fl  ow cytometry on a FACSCalibur us-
ing CellQuest Pro software (BD); further analysis was performed using FlowJo 
software (Tree Star, Inc.). MLN cells were restimulated by plating cells in me-
dium alone, in the presence of 50   μ  g/ml of   T. muris   ES antigen, or with 1   μ  g/ml 
each of soluble anti-CD3 and anti-CD28 antibodies. After 72 h in culture, 
cells were stimulated with PMA and ionomycin in the presence of brefeldin A 
for 4  –  5 h. Cell-free supernatants were harvested and analyzed for cytokine se-
cretion by sandwich ELISA (eBioscience). The cells were harvested and ana-
lyzed for cytokine production as described for the ex vivo analysis. 
  Tissue staining and RELM     responses.     At necropsy, cecal sections were 
removed and fi  xed in 4% paraformaldehyde or snap frozen in OCT medium 
(Tissue Tek; Sakura Inc.). 5-  μ  m paraffi   n-embedded sections were cut and 
stained with hematoxylin and eosin (H  &  E) or periodic acid-Schiff   (PAS)/
Acian blue, or by IF for RELM     and GOB5 for visualization of goblet cell re-
sponses. IF staining was performed as previously described (  2  ). IF for TSLP 
was performed on cryosections of the large intestine and cecum using a biotin-
ylated monoclonal anti-TSLP antibody (eBioscience). Fecal protein isolation 
was performed as previously described (  29  ). Samples were equalized by protein 
content and analyzed by SDS-PAGE, and then immunoblotted for RELM     
using a polyclonal rabbit anti  –  murine RELM     antibody (PeproTech). 
  BMDCs and BMDC/T cell co-culture.     BMDCs were derived as follows. 
Bone marrow from WT C57BL/6 mice was plated in 6-well cell-culture 
plates in RPMI 1640 supplemented with 100 U/ml penicillin, 100   μ  g/ml 
streptomycin, 5   ×   10      5   M 2-ME, 10% FBS, 2 mM   l-  glutamine, and 20 ng/ml 
GM-CSF (PeproTech). Media was changed at days 3, 6, and 8; cells were har-
vested at day 9. BMDCs were plated out at 4   ×   10  6   cells/ml and mixed 1:1 
with either media alone, IEC-Sup, or rTSLP (fi  nal concentration of 10 or 
100 ng/ml; R  &  D Systems) for 16  –  18 h. Cells were stimulated with 10 ng/ml 
LPS. At various time points, cell-free supernatants were harvested for analysis 
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